Oracle appoints Cleveland Clinic CEO Dr. T. Mihaljevic to its board (8-K, May 2026)
Oracle disclosed that on May 6, 2026 its board unanimously appointed Dr. Tomislav Mihaljevic, CEO and President of Cleveland Clinic, as a director (effective immediately), expanding the board to 13. Bringing on the head of a major medical institution reflects Oracle's healthcare focus.
Filing key facts
- CompanyORACLE CORP（ORCL）
- FormCurrent report (8-K)
- ExchangeNYSE,NYSE
- Industry (SIC)Services-Prepackaged Software
- Filing date2026-05-12
- Period2026-05-06
- 8-K events5.02 Director/officer changes; compensation、7.01 Regulation FD disclosure、9.01 Financial statements and exhibits
- Accession no.0001193125-26-219708
Key points
- Cleveland Clinic CEO/President Dr. T. Mihaljevic unanimously appointed director (effective May 6, 2026)
- Board expanded to 13; standard RSU and cash compensation for non-employee directors granted
- No third-party arrangement and no related-party transaction stated (Items 5.02 / 7.01)
- Press release quotes Oracle co-CEOs (Sicilia and Magouyrk) = confirms the co-CEO structure
Oracle disclosed a board appointment effective May 6 in a current report (8-K) filed May 12, 2026 (Item 5.02 Election of Directors / Item 7.01 Regulation FD Disclosure).
The board unanimously appointed Dr. Tomislav Mihaljevic, M.D., as a director (effective immediately), expanding the board to 13. Per the attached press release (Exhibit 99.1), he has served since January 2018 as CEO and President (Morton L. Mandel CEO Chair) of Cleveland Clinic (a nonprofit integrated academic medical center / integrated healthcare system). Previously he was CEO of Cleveland Clinic Abu Dhabi and head of its cardiovascular institute, and served on the board of GE Healthcare — a healthcare executive with a background as a cardiac surgeon.
Upon appointment, he was granted the standard restricted stock units (RSUs) for non-employee directors on May 31 and receives standard cash compensation. The 8-K states there is no arrangement with any third party regarding the appointment and no related-party transaction with Oracle.
In the press release, Oracle co-CEOs Mike Sicilia and Clay Magouyrk comment — confirming Oracle's co-CEO structure. Bringing the head of a leading medical institution onto the board reflects Oracle's direction of focusing on healthcare since the Cerner acquisition.
Why it matters
A board appointment in which Oracle — focused on healthcare since the Cerner acquisition — brings on the head of a leading medical institution. A useful read on Oracle's strategic direction for anyone tracking healthcare × cloud / AI.
FAQ
Who is Dr. Mihaljevic?
Why would Oracle add a CEO-level healthcare figure to its board?
Does Oracle have a co-CEO structure?
Sources (primary)
This article is an independent organization based on the U.S. SEC official disclosures below. Always verify the exact, latest details with the original filing.
- SEC EDGAR (filing index)
- Primary document (original)
- Accession no.：0001193125-26-219708